CME Group Inc. 8-K Summary: 2024 Annual Meeting Results
Business Context and Reporting Period
This Form 8-K reports the results of CME Group Inc.'s 2024 Annual Meeting of Shareholders held on May 9, 2024. The report was filed on May 13, 2024. As of the record date (March 11, 2024), the Company had 360,025,217 shares of Class A and Class B common stock issued and outstanding.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on corporate governance and shareholder voting outcomes.
Material Changes and Voting Results
Shareholder participation was significant, with 314,467,507 shares of Class A and B stock present (87.34% of issued and outstanding shares). The following proposals were voted upon:
- Election of Equity Directors: All 17 nominees for Equity Directors were elected to serve until 2025. Voting was conducted by Class A and Class B shareholders as a single class.
- Ratification of Auditors: Shareholders ratified the appointment of Ernst & Young LLP as the independent public accounting firm for 2024.
- Executive Compensation: The advisory vote on the compensation of named executive officers was approved.
- Election of Class B Directors: No quorum was achieved for the elections of Class B-1, B-2, and B-3 directors. Consequently, the incumbent directors for these classes (William W. Hobert, Patrick J. Mulchrone, Robert J. Tierney Jr., Michael G. Dennis, Patrick W. Maloney, and Elizabeth A. Cook) will continue to serve as "holdover" directors under Delaware law and the Company's bylaws until their successors are elected at the 2025 Annual Meeting.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the procedural results of the shareholder meeting.
Key Facts for Investor Verification
- Verify the status of the "holdover" Class B directors and confirm if the Company plans to call a special meeting to elect successors before the 2025 Annual Meeting.
- Review the specific vote counts for the Equity Directors, noting that while all were elected, some received significant "Against" votes (e.g., Phyllis M. Lockett received over 103 million votes against).
- Confirm the total number of broker non-votes (23,764,212) and their impact on the quorum for Class B director elections.